International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • S Novello - (Author)
  • V Torri - (Author)
  • C Grohe - (Author)
  • S Kurz - (Author)
  • M Serke - (Author)
  • T Wehler - (Author)
  • A Meyer - (Author)
  • D Ladage - (Author)
  • M Geissler - , Knowledge and technology transfer (Work Group) (Author)
  • I Colantonio - (Author)
  • C Cauchi - (Author)
  • E Stoelben - (Author)
  • A Ceribelli - (Author)
  • C Kropf-Sanchen - (Author)
  • G Valmadre - (Author)
  • G Borra - (Author)
  • M Schena - (Author)
  • A Morabito - (Author)
  • A Santo - (Author)
  • V Gregorc - (Author)
  • R Chiari - (Author)
  • M Reck - (Author)
  • G Schmid-Bindert - (Author)
  • G Folprecht - , Department of internal Medicine I (Author)
  • F Griesinger - (Author)
  • A Follador - (Author)
  • P Pedrazzoli - (Author)
  • A Bearz - (Author)
  • O Caffo - (Author)
  • NJ Dickgreber - (Author)
  • L Irtelli - (Author)
  • G Wiest - (Author)
  • V Monica - (Author)
  • L Porcu - (Author)
  • C Manegold - (Author)
  • GV Scagliotti - (Author)

Details

Original languageUndefined
JournalAnnals of Oncology
Publication statusPublished - 2022
Peer-reviewedYes

External IDs

Scopus 85118540643

Keywords

Sustainable Development Goals